MB, Levis & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
MB, Levis & Associates's MRK Position: Q3 2026 in Review
MB, Levis & Associates increased its Merck (MRK) stake by 4.4% in Q3 2026, buying an estimated $70.6K and bringing the position to 12,243 shares worth $1.78M. The position accounts for 0.65% of the portfolio, ranked #29.
MB, Levis & Associates first reported a position in MRK in Q4 2022 and has held it in 16 quarters since. 2,434 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- MB, Levis & Associates held 12,243 shares of Merck worth $1.78M as of Q3 2026.
- MB, Levis & Associates bought 511 Merck shares in Q3 2026, an estimated $70.6K.
- Merck made up 0.65% of MB, Levis & Associates's portfolio in Q3 2026, its #29 holding.
- MB, Levis & Associates first reported a position in Merck in Q4 2022 and has held it in 16 quarters since.
- 2,434 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on MB, Levis & Associates's 13F filing for Q3 2026, filed 16 Oct 2026.